Microspheres of mixed proteins by Angel, U. et al.
DOI: 10.1002/chem.200902098
Microspheres of Mixed Proteins
Ulyana Angel (Shimanovich),*[a, b] Devorah Matas,[b] Shulamit Michaeli,[b]
Artur Cavaco-Paulo,[c] and Aharon Gedanken*[a]
Introduction
Ultrasonic emulsification is a well-known process and
occurs in biphasic systems. Emulsification is necessary for
microcapsule formation. Protein microspheres have a wide
range of applications, including drug and oxygen delivery
systems,[2–3,12] contrast agents for sonography,[4] and MRI.[5–7]
Micrometer-sized air-filled or liquid-filled proteinaceous
microspheres (PMs) were synthesized from various kinds of
proteins, such as bovine serum albumin (BSA),[8–10] human
serum albumin (HAS),[11] and hemoglobin (Hb)[12] by the so-
nochemical method developed by Suslick and co-workers. In
the late 1960s, a modified polymerization method for the
preparation of proteinaceous microspheres was developed
by Rhodes, Scheffel, Wagner, and Zolle et al.[13–15] The mi-
crosphere formation was accomplished by either heat dena-
turation at various temperatures or by cross-linking with car-
bonyl compounds in the ether phase. Other cross-linking
agents, such as glutaraldehyde, were also used. Furthermore,
air-filled human serum albumin microspheres were made by
Dick and Feinstein[16,17] as contrast agents in echosonogra-
phy. However, these methods yielded microspheres with a
short storage life, low microbubble stability, or high toxicity.
The first liquid-filled proteinaceous microspheres were pre-
pared by Suslick. They were made of BSA and were filled
with n-dodecane, n-decane, n-hexane, cyclohexane, or tolu-
ene. The synthesis was conducted under a high-intensity ul-
trasonic probe, and 1.5109 microcapsules per mL were ob-
tained upon sonicating the precursor solution under air or
O2. The average diameter of the PM was 2.5 mm with a
narrow size distribution (Gaussian distribution= l.0 mm).
The mechanism of the sonochemical formation of PM has
been discussed previously.[18] According to this mechanism,
the microspheres are formed by chemically cross-linking cys-
teine residues of the protein with HO2 radicals formed
around a micron-sized gas bubble or a nonaqueous droplet.
The chemical cross-linking is responsible for the formation
of the microspheres, and is a direct result of the chemical ef-
fects of ultrasound radiation on an aqueous medium.
In the current fundamental studies, we have extended
Suslicks method and applied it to more than one protein,
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and have succeeded in forming mixed protein microspheres
(MPMs). For this purpose we have used GFP (recombinant
green fluorescent protein),[19] CFP-GBP-YFP(cyan fluores-
cent protein, glucose binding protein, and yellow fluorescent
fused protein),[20] and BSA proteins as candidates for build-
ing mixed protein microspheres. It is worth mentioning that
all the studied proteins have cys (cysteine) residues[21] that
are responsible for and capable of the formation of SS
bonds (cross-linking) and facilitate the formation of the
MPMs. Two of the three different proteins used in the cur-
rent experiments, GFP and CFP-GBP-YFP, are fluores-
cent.[22] The GFP protein has a major excitation peak at a
wavelength of 395 nm and a minor one at 475 nm. Its emis-
sion peak is at 509 nm, which is in the lower green portion
of the visible spectrum. CFP-GBP-YFP was excited at
436 nm, and the emission measured at 480 nm. Three possi-
ble arrangements can be foreseen as originating from the as-
sembly of two different kinds of proteins in forming micro-
sphere structures. First, the combined two proteins together
form the microspheres walls. Second, the first protein forms
the microspheres walls, while the second protein is encapsu-
lated inside the liquid-filled proteinaceous microsphere
bubble. Third, each kind of protein forms separated one-
protein microspheres. To prove the arrangement of different
proteins in a microsphere structure, we analyzed and charac-
terized the products by light microscopy (Apo-Tome Axio-
Imager.z1 microscope)[23] and by DLS (dynamic light scatter-
ing) measurements. Microscopic observation was carried out
for the microspheres to determine the arrangement of fluo-
rescent proteins in MPM structures. In addition, the micro-
scopic images (the z-stack images) were analyzed by the
Imaris software image analysis program,[24–25] which pro-
vides a refined data set and, ultimately, a more precise eval-
uation of protein expression patterns. The Imaris program
enables one to flip and rotate the z-stack in real time, and
also to employ the Clipping Plane command that allows a
microcapsule to be cut in half for internal review. This is
very useful for investigating protein localization. The
Imaris program enables the possibility of localizing the flu-
orescent proteins GFP and CFP-GBP-YFP in the MPM
structure.
MPMs have a potential application as a fluorescent detec-
tion of microspheres. In cell and molecular biology, the
mixed protein microspheres could be introduced into organ-
isms by endosythosis to follow the microspheres in the cell.
In addition, since we have already demonstrated that drugs
can be encapsulated in a PM in a 3 min sonication pro-
cess,[26–27] the fluorescence of the MPM can help in tracing
the release of the drug upon the disintegration of the
sphere. The modified forms of MPM (e.g., MPM, which con-
sists of two different biologically active proteins) could be
used as a biosensor. The mixed proteins can serve for the
microscopic monitoring of proper targeting. We propose
using a mixture of fluorescent protein with a nonfluorescing
protein that contains a mutation. Since these proteins are
found in the same microshpere if one is properly targeted
the second goes along. In this way, we can assure that we
targeted the protein to the proper nuclear locale. If we use a
nuclear protein, we anticipate localizing the protein to the
nucleus. The advantages of MPMs over the single PMs are
as follows: 1) To make one PM of a fluorescent protein
would be very expensive because of its price. On the other
hand, to synthesize fluorescent microspheres (MPMs) we
need a small amount of the expensive fluorescent proteins
and a large amount of the less expensive nonfluorescent
protein. 2) The MPM enables two parts to be targeted in the
organism at the same time.
Results and Discussion
The formation, characterization, and properties of the sono-
chemically made PM were recently reviewed.[28] The mecha-
nism of the MPMs formation is similar to the mechanism of
PMs formation. Aqueous sonochemistry caused by the im-
plosive collapse of bubbles produces COH and CH. The radi-
cals so produced form H2, H2O2, and, in the presence of O2,
superoxide CHO2. Hydroxyl, superoxide, and peroxide radi-
cals are all potential protein cross-linking agents. The cys-
teine, which is present in BSA, CFP-GBP-YFP, and GFP
proteins, is oxidized by the superoxide radical. The micro-
capsules are held together by protein cross-linking through
disulfide linkages from cysteine oxidation.
Although we have previously shown that the microspheri-
zation of proteins can also happen in the absence of cys-
teines,[21] in the case in which cysteine is not present, we had
to lower the pH to form the spheres. In the current case, in
which cysteines exist in the protein, under neutral pHs, the
SS bonds are the dominant factor stabilizing the sphere.
After the sonication, we could identify three different
kinds of microspheres that were synthesized sonochemically:
pristine BSA microspheres (one-protein microspheres), pris-
tine (CFP-GBP-YFP)/GFP microspheres (one-protein mi-
crospheres), and BSA-(CFP-GBP-YFP)/BSA-GFP MPM
(mixed protein microspheres). A schematic diagram of the
arrangement and assembly of proteins leading to micro-
sphere formation is presented in Figure 1.
The morphology of the microspheres was determined by
using light microscopy (Apo-Tome AxioImager.z1 micro-
scope). Figure 2 shows a micrograph depicting three kinds
of microspheres: a) pristine BSA, b) BSA-(CFP-GBP-YFP),
and c) BSA-GFP. As expected, the BSA microspheres are
colorless and their average size was calculated to be 2.34 mi-
crons.
Figure 2b shows the microspheres obtained upon the soni-
cation of the BSA and CFP-GBP-YFP proteins. The figure
does not represent the regular size of the blue microspheres.
We have chosen to present microspheres that are much
larger than the average blue microspheres obtained in the
reaction, because these large microspheres exhibit a much
stronger fluorescence signal than the BSA-(CFP-GBP-YFP)
spheres. On the other hand, the color detected for the small-
er spheres was much weaker. A strong blue sphere is ob-
served at the center of each of the large two spheres. The
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larger of the two blue spheres is about 25 microns in size
and the smaller one is 12 microns. These MPMs were micro-
tomed for further studies. The small microspheres behind
and above the blue spheres are black and are surrounded by
a white corona. Since the microspheres have different sizes,
it is not possible to focus the illuminating beam on all the
particles simultaneously. Thus, the corona is a result of fo-
cusing the illuminating beam on the blue spheres, and when
the beam is focused on the black spheres the corona is not
detected. At this stage, without further analysis, it seems
that the blue microspheres are attributed to the CFP-GBP-
YFP proteins or to the MPMs of BSA-(CFP-GBP-YFP),
whereas the small black microspheres are due to BSA.
The microsphere size distribution of the three products
(BSA, BSA-(CFP-GBP-YFP), and BSA-GFP) was exam-
ined by DLS measurements. When pristine BSA was soni-
cated, the DLS results yielded spheres with an average size
of 2.34 microns (for BSA microspheres). When a mixture of
BSA and GFP was sonicated, a bimodal size distribution
was found in the DLS measurements. The average size for
the major component of the BSA-GFP MPM was 1.406 mm
(92.6%). The minor component of 7.4% showed an average
size of 244 nm.
Only one DLS peak is obtained for the products of the
sonicated mixture of BSA-(CFP-GBP-YFP). The average
size of the spheres was found to be 3.525 mm. The results of
the calculated size distribution of the microspheres are pre-
sented in Figure 3. The picture indicates that tBSA-(CFP-
GBP-YFP) is the largest sphere, followed by the BSA
spheres, and the BSA-GFP particles are the smallest. We at-
tribute this order to the molec-
ular weight of GFP and (CFP-
GBP-YFP) proteins. The mo-
lecular weight and the size of
the GFP is the smallest, which
makes the spheres smaller. This
number is increased in the
(CFP-GBP-YFP) protein,
making the spheres larger than
in BSA-GFP. We assign the
minor component (7.4%) in the
BSA-GFP mixture with an
average size of 244 nm to the
GFP (one-protein) micro-
spheres. In both mixtures, BSA-
GFP and BSA-(CFP-GBP-
YFP), a small amount (~5%)
of pristine BSA-BSA (average
size 2.3 microns) micro-
spheres are detected. Since
their contribution to the size
distribution is negligible, the
size order depicted in Figure 3
is a true presentation of the mi-
crospheres sizes.
The different ways of control-
ling the size of proteinaceous
microspheres were previously studied.[28]
To prove the arrangement of different proteins in the mi-
crosphere structure, we analyzed and characterized the
products by light microscopy (Apo-Tome AxioImager.z1 mi-
croscope). We analyzed the Apo-Tome images by the
Imaris program to demonstrate the location of the fluores-
cent protein in the MPM structure. The Imaris program en-
abled us to “cut” the microspheres into different planes (xy,
xz, and yz planes), which allowed us to locate the different
proteins in the microsphere structure (see the Supporting
Information).
An example of a “reverse” BSA-(CFP-GBP-YFP) micro-
sphere is shown in Figure 4a, in which the fluorescent CFP-
GBP-YFP protein was encapsulated inside the liquid-filled
BSA microsphere bubble. Figure 4b shows a BSA-(CFP-
GBP-YFP) mixed protein microsphere, in which the walls
are a mixture of the two proteins, BSA and CFP-GBP-YFP.
The light emitted from the microspheres walls does not
spread homogeneously over the whole surface and only
patches of blue are observed. We can clearly identify frag-
ments of the blue color originating from the MPM wall that
are assigned to the fluorescent CFP-GBP-YFP protein. Fig-
ure 4c and d show three kinds of microspheres in the same
solution, PM, MPM, and “reverse” MPM. Unlike Figure 4a,
in which homogeneous fluorescence originated throughout
the content of the sphere, Figure 4d reveals many colored
spheres in which the green color is located in only a small
part of the volume. These kinds of spheres are clearly mixed
spheres, in which the two proteins, BSA and GFP, construct
the walls of the sphere. Figure 4c illustrates BSA-(CFP-
Figure 1. Schematic diagram of the arrangements and assembly of proteins leading to microsphere formation.
A=any nonfluorescent protein; B=any fluorescent protein. 1) The combined two proteins together form the
microspheres walls. 2) The first protein forms the microspheres walls, whereas the second protein is encapsu-
lated inside the liquid-filled proteinaceous microsphere bubble. 3) Each kind of protein forms separated one-
protein microspheres.
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GBP-YFP) MPMs and pristine BSA spheres. As stated pre-
viously, these BSA spheres are only 5% of the total spheres
observed in our studies.
The calculated abundance of each kind of microsphere
(“reverse” microspheres, BSA-(CFP-GBP-YFP)/BSA-GFP
MPMs, pristine BSA, and pristine GFP/(CFP-GBP-YFP)
spheres) was studied by using the Scion image analysis pro-
gram. These calculations have revealed differences in the
particle size of the four kinds of the above-mentioned mi-
crospheres. To make this kind of analysis, we first need to
identify each kind of microsphere. In “reverse” micro-
spheres, in which the fluorescent (GFP/CFP-GBP-YFP) pro-
tein was encapsulated inside the liquid-filled BSA PM, the
light (green for GFP or blue for CFP-GBP-YFP protein)
was emitted from the inner part of the spheres. The BSA-
(CFP-GBP-YFP)/BSA-GFP MPMs emitted the light, which
is not homogeneously spread, from the microspheres walls.
The pristine BSA spheres have no fluorescent signal. Pris-
tine GFP or CFP-GBP-YFP PMs emitted the homogeneous-
ly spread green or blue light, respectively, from the PM
walls.
Figures 5 and 6 present the percentages and average sizes
of the different structures for MPMs of BSA-GFP and
BSA-(CFP-GBP-YFP), respectively. Figure 5 is divided into
a and b, each emphasizing different microspheres. In Fig-
ure 5a, in which the green color dominates, it is easier to
detect the microspheres with green patches or with a com-
plete green wall. On the other hand, Figure 5b emphasizes
the more blackish colors and, therefore, helps to detect the
pristine BSA microspheres. The results show that the major
components of the BSA-GFP and BSA-(CFP-GBP-YFP)
solutions after the sonication are mixed protein micro-
spheres, namely, microspheres the skeleton of which is com-
posed of the two proteins. Figure 5c shows the abundance of
the different kinds of microspheres for the BSA-GFP solu-
tion. For this solution, four types of microspheres were cre-
ated: a) pristine BSA microspheres (3.6%) with an average
size of 2.3 mm, b) pristine GFP microspheres (3.7%) with an
average size of 435 nm, c) reverse GFP-BSA MPMs (8.4%)
with an average size of 1.657 mm, and d) GFP-BSA MPM
(84.3%) with an average size of 1.25 mm. For the BSA-GFP
solution we got a total 92.7% of GFP-BSA MPMs with an
average size of 1.453 mm. These results confirm the previous
calculation of the Gaussian distribution of particle size
(Figure 3), in which the average
size for the major component
(BSA-GFP MPM) was
1.406 mm (92.6%). The same
calculations were made for the
BSA-(CFP-GBP-YFP) solution
(Figure 6), in which the follow-
ing results were observed:
a) pristine BSA microspheres
(4.3%) with an average size of
2.1 mm, b) pristine CFP-GBP-
YFP microspheres (4.3%) with
an average size of 5.66 mm,
c) reverse (CFP-GBP-YFP)-
BSA MPMs (7.1%) with an
average size of 1.5 mm, and
Figure 2. a) Apo-Tome image of BSA-BSA one-protein microspheres.
b) Apo-Tome image of BSA-(CFP-GBP-YFP) MPM. c) Apo-Tome
image of BSA-GFP MPM.
Figure 3. DLS measurement of MPM size distribution. The average sizes of three examples are: a) 2.34 mi-
crons (for BSA microspheres), b) average size for BSA-GFP MPM is 1.406 mm (92.6%) and 244.0 nm (7.4%),
c) average size for BSA-(CFP-GBP-YFP) spheres is 3.525 mm.
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d) (CFP-GBP-YFP)-BSA MPM (84.3%) with an average
size of 3.3 mm.
We have also studied the influence of different ratios of
BSA: GFP/(CFP-GBP-YFP) on the composition of the
MPM. Increasing the BSA fluorescent protein ratio in the
precursor solution from 2.2:1 to
6.6:1 caused an increase in the
percentage of pristine BSA mi-
crospheres in the resulting solu-
tion (from ~3–5 to ~12%).
This result is explained by the
larger amount of BSA, which
will favor the formation of pris-
tine BSA microspheres.
Conclusions
In this work, we have synthe-
sized mixed proteinaceous mi-
crospheres by the sonochemical
method. We have proved that
there are three possible ar-
rangements that can be ob-
tained from the assembly of
two different kinds of proteins
in microsphere structures. First,
the combined two proteins
form the microspheres walls.
Second, the first protein forms
the microspheres walls and the
second one is encapsulated
inside the liquid-filled proteina-
ceous microsphere bubble.
Third, each kind of protein
forms one-protein microspheres.
The Imaris images indicated
the location of the different
proteins in the microsphere
structures. We have found that
there are differences in the par-
ticles size in the case of one-
protein microspheres against
mixed protein microspheres.
These differences result from
the molecular weight of pro-
teins.
We are currently trying to
verify our results by using
FPLC measurements. We are
also planning to bind antibodies
that are specific to CFP-GBP-
YFP or GFP to the MPM sur-
face to find out the protein per-
centage in the microsphere
walls.
Experimental Section
Sonochemical preparation of BSA microspheres : Bovine serum albumin
(BSA, molecular weight 66 kDa), 96–99% albumin (Sigma) was used
Figure 4. a) The Imaris image for BSA-(CFP-GBP-YFP) MPM. The BSA protein forms the microspheres
walls and the CFP-GBP-YFP protein is encapsulated inside the liquid-filled proteinaceous microsphere
bubble. b) The CFP-GBP-YFP protein forms the microspheres wall. c) The Imaris image with BSA-(CFP-
GBP-YFP) MPM and one-protein microspheres: BSA-BSA (without a fluorescent signal) and (CFP-GBP-
YFP)-(CFP-GBP-YFP) (with a strong fluorescent signal in the blue portion of the visible spectrum). d) Apo-
Tome (z-stack) image of BSA-GFP MPM.
Figure 5. The percentage and size distribution of the various types of the BSA-GFP microspheres. a) Apo-
Tome (z-stack one-color channel) image of BSA-GFP MPM. b) Apo-Tome image of BSA-GFP MPM (a and b
are the same images). This figure was used for monitoring the percentage and average size of the pristine
BSA microspheres. c) Histogram for abundance of each of the MPM structures. The calculations of the per-
centage of each of the MPM structures and particle size distribution employed the Sicon image software pro-
gram: a= the abundance of pristine BSA microspheres (3.6%) with an average size of 2.3 mm, b=pristine
GFP microspheres (3.7%) with an average size of 435 nm, c= reverse GFP-BSA MPMs (8.4%) with an aver-
age size of 1.657 mm, and d=GFP-BSA MPM (84.3%) with an average size of 1.25 mm.
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without any further purification. The preparation of BSA microspheres
followed the typical synthesis of proteinaceous microspheres, as de-
scribed previously.[29] In brief, dodecane (20 mL, 98.0% Fluka) was lay-
ered over a water solution (30 mL) of 5% w/v protein. The volume ratio
between the 5% (w/v) BSA aqueous solution and dodecane was kept
constant at 3:2, respectively.
General conditions for the preparation of MPM : Herein we outline the
common conditions used in the preparation of MPMs. MPMs have been
synthesized with a high-intensity ultrasonic probe (Sonic and Materials,
VC-600, 20 kHz, 0.5 in. Ti horn, at 78% amplitude). The volume of the
acoustic chamber was 25 mL and the total volume of all the ingredients
was 17.7 mL. The bottom of the high-intensity ultrasonic horn was posi-
tioned at the aqueous–organic interface, employing an acoustic power of
about 150 Wcm2 with an initial temperature of 22 8C in the reaction cell.
The sonication lasted for 3 min at 22 8C by using an ice-cooling bath to
maintain the low temperature. At the end of the reaction, the tempera-
ture in the reaction cell reached 28 8C. The rise in temperature from 22
to 28 8C (measured by a thermocouple) did not change the conformation
of the proteins. The temperature in the reaction cell should not rise
above the denaturation temperature of the proteins (the recommended
temperature is 5 8C below the denaturation temperature of the proteins).
A separation flask was used to separate the product from the mother so-
lution. The separation was accomplished within a few minutes due to the
lower density of the microspheres, relative to the density of water. To
obtain a more complete separation of the proteinaceous microspheres
from the mother solution, the separation flasks were placed in a refriger-
ator (4 8C) for 24 h. After the separation, the residual aqueous phase and
the organic solvent (dodecane) were removed and the product was re-
suspended in water.
While the GFP was purchased from Alpha-Diagnostic, the CFP-GBP-
YFP was not purchased from outside sources and was purified according
to the following description.
CFP-GBP-YFP purification : A BL21 bacterial E. coli strain[30] trans-
formed with a plasmid expressing the desired protein was induced for
protein synthesis. The protein was purified by using a Talon metal affinity
resin (Clontech). The CFP-GBP-YFP protein was identified by Western
Blot analysis[31] and reveals the presence of the CFP-GBP-YFP protein at
90 kDa.[32]
Preparation of BSA-(CFP-GBP-YFP) microspheres : The three starting
materials used for the preparation of mixed proteinaceous BSA-(CFP-
GBP-YFP) microspheres were: 1) a 5% w/v aqueous solution of BSA
(bovine serum albumin, 96–99% Sigma–Aldrich), 2) a CFP-GBP-YFP
protein aqueous solution (0.15 mgmL1), and 3) dodecane (98.0%
Fluka). The amount of water-soluble CFP-GBP-YFP protein in all the re-
actions varied from 0.5 to 1.5 mL. The ratio of BSA:(CFP-GBP-YFP)
varied from 2.2:1 to 6.6:1. The CFP-GBP-YFP protein was added to the
aqueous solution of the BSA. The volume ratio of the 5% (w/v) BSA
aqueous solution and dodecane was kept constant, 3:2, respectively.
Preparation of BSA-GFP microspheres : For the preparation of mixed
proteinaceous GFP-BSA microspheres, the following reactants were
used: 1) a 5% w/v aqueous solution of BSA (bovine serum albumin, 96–
99% Sigma–Aldrich), 2) GFP (recombinant green fluorescent protein;
Alpha-Diagnostic), 3) dodecane (98.0% Fluka). The volume ratio of the
5% (w/v) BSA aqueous solution and dodecane was kept constant, 3:2,
respectively. The GFP protein was added to the aqueous solution of the
BSA (ratio BSA: GFP varied from 2.2:1 to 6.6:1).
Characterization methods : See the Supporting Information.
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